Atlas Trials

Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label Study

Clinical trial NCT06234007 · RECRUITING

Trial details

NCT number
NCT06234007
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Rectal Cancer
Start date
2023-12-01
Primary completion
2024-12-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.